These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2182246)

  • 41. Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials.
    Leonardi-Bee J; Bath PM; Bousser MG; Davalos A; Diener HC; Guiraud-Chaumeil B; Sivenius J; Yatsu F; Dewey ME;
    Stroke; 2005 Jan; 36(1):162-8. PubMed ID: 15569877
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aspirin and dipyridamole in the prevention of coronary disease and coronary artery bypass graft occlusion.
    Chong BH
    Aust N Z J Med; 1992 Dec; 22(6):645-6. PubMed ID: 1489286
    [No Abstract]   [Full Text] [Related]  

  • 43. Dissolution of angiographically detected intracoronary thrombus for unstable angina pectoris after aspirin therapy.
    Bates ER; Mickelson JK
    Am J Cardiol; 1987 Sep; 60(8):728-9. PubMed ID: 3661445
    [No Abstract]   [Full Text] [Related]  

  • 44. Preliminary study of effect of aspirin and dipyridamole on platelet adhesiveness and fibrinolytic activity in acute myocardial infarction.
    Jhawar BK; Trivedi HH; Bhargava RK; Misra NP
    J Assoc Physicians India; 1978 Sep; 26(9):805-9. PubMed ID: 370078
    [No Abstract]   [Full Text] [Related]  

  • 45. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2006 Apr; (2):CD001820. PubMed ID: 16625549
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Anti-adhesion and anti-coagulant substances in thrombosis therapy. Acetylsalicylic acid and Persantin in the spotlight].
    Stormorken H
    Tidsskr Nor Laegeforen; 1971 Feb; 91(6):449-50. PubMed ID: 5546533
    [No Abstract]   [Full Text] [Related]  

  • 47. Intracoronary dipyridamole reduces the incidence of abrupt vessel closure following PTCA: a prospective randomised trial.
    Heintzen MP; Heidland UE; Klimek WJ; Leschke M; Kelm M; Schwartzkopff B; Vester EG; Michel CJ; Strauer BE
    Heart; 2000 May; 83(5):551-6. PubMed ID: 10768906
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency.
    Sharma GV; Khuri SF; Josa M; Folland ED; Parisi AF
    Circulation; 1983 Sep; 68(3 Pt 2):II218-21. PubMed ID: 6347428
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk factors, interventions and therapeutic agents in the prevention of atherosclerosis-related ischaemic diseases.
    Verstraete M
    Drugs; 1991; 42 Suppl 5():22-38. PubMed ID: 1726214
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Use of aspirin in the primary prevention of vascular thrombi. A comparative study with other anti-aggregant drugs].
    Escudero MC; Alvarez L; Rodríguez V; de Haro J; Millán I; Castillo-Olivares JL
    Rev Esp Cardiol; 1989 Oct; 42(8):536-40. PubMed ID: 2602610
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Prevention of thrombosis in the after-care of coronary dilatation and thrombolysis].
    Weber MA; Lorenz RL; Schramm W; Theisen K
    Z Kardiol; 1986; 75 Suppl 5():107-11. PubMed ID: 2950673
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adjunctive intracoronary dipyridamole in the interventional treatment of small coronary arteries: a prospectively randomized trial.
    Heidland UE; Heintzen MP; Michel CJ; Strauer BE
    Am Heart J; 2000 Jun; 139(6):1039-45. PubMed ID: 10827385
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does dipyridamole have antithrombotic potential?
    Loeliger EA
    Thromb Haemost; 1985 Jun; 53(3):437. PubMed ID: 4049315
    [No Abstract]   [Full Text] [Related]  

  • 54. [Action mechanism and clinical indications for thrombocyte aggregation inhibitors].
    Oelz O
    Schweiz Med Wochenschr; 1979 Mar; 109(10):348-53. PubMed ID: 424707
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of perioperative platelet inhibition on postcarotid endarterectomy mural thrombus formation. Results of a prospective randomized controlled trial using aspirin and dipyridamole in humans.
    Findlay JM; Lougheed WM; Gentili F; Walker PM; Glynn MF; Houle S
    J Neurosurg; 1985 Nov; 63(5):693-8. PubMed ID: 3903068
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current issues in thrombosis prevention with antiplatelet drugs.
    de Gaetano G; Cerletti C; Dejana E; Vermylen J
    Drugs; 1986 Jun; 31(6):517-49. PubMed ID: 3525085
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2007 Jul; (3):CD001820. PubMed ID: 17636684
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus.
    Valentine N; Van de Laar FA; van Driel ML
    Cochrane Database Syst Rev; 2012 Nov; 11():CD005449. PubMed ID: 23152231
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anti-thrombotic drugs in the treatment of coronary heart disease: the present situation with aspirin.
    Born GV
    Z Kardiol; 1990; 79 Suppl 3():147-50. PubMed ID: 2099037
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studies on the progression and regression of coronary and peripheral atherosclerosis in the cynomolgus monkey. I. Effects of dipyridamole and aspirin.
    Hollander W; Kirkpatrick B; Paddock J; Colombo M; Nagraj S; Prusty S
    Exp Mol Pathol; 1979 Feb; 30(1):55-73. PubMed ID: 217724
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.